Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02244619 · ClinicalTrials.gov registry record · Phase 4
PO vs. IV Acetaminophen Given Perioperatively for 24 hr Post-op Pain Control Following Total Hip or Knee Replacement
A Phase 4 study of Post-op Pain, sponsored by Kettering Health Network.
- Completed
- Registry status
- Phase 4
- Development phase
- 515
- Enrollment target
- 1
- Study location
NCT02244619 is a Phase 4 study of Post-op Pain that has completed, run by Kettering Health Network. The registered enrollment target is 515 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02244619, a Phase 4 study of Post-op Pain, has completed, sponsored by Kettering Health Network.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 515 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to evaluate post-op pain requirements in patients undergoing hip or knee replacement surgery who perioperatively receive either Oral acetaminophen or IV acetaminophen
Conditions Studied
Interventions
- DRUG IV acetaminophen
- DRUG Oral acetaminophen
Study Locations (1)
Ohio
- Kettering Medical Center - Kettering
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 515 participants |
| Start Date | 2014-09 |
| Est. Completion | 2016-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02244619
The ClinicalTrials.gov registry entry for NCT02244619 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 515 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kettering Health Network, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Post-op Pain appearing as the primary indexed condition, and to 2 interventions - of which IV acetaminophen is the first listed.
NCT02244619 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT02244619 about?
NCT02244619 is a clinical study titled "PO vs. IV Acetaminophen Given Perioperatively for 24 hr Post-op Pain Control Following Total Hip or Knee Replacement". The purpose of the study is to evaluate post-op pain requirements in patients undergoing hip or knee replacement surgery who perioperatively receive either Oral acetaminophen or IV acetaminophen
What is the current status of trial NCT02244619?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 515 participants. The study started on 2014-09. Estimated completion is 2016-04.
What conditions does trial NCT02244619 study?
This clinical trial studies the following conditions: Post-op Pain.
What interventions are being tested in trial NCT02244619?
The interventions under investigation include: IV acetaminophen (DRUG), Oral acetaminophen (DRUG).
Who is sponsoring clinical trial NCT02244619?
This trial is sponsored by Kettering Health Network, which has 14 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02244619 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Post-op Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.